T. Rowe Price Associates
ONXX

T. Rowe Price Associates’s ONYX PHARMACEUTICALS INC ONXX Stock Holding History

T. Rowe Price Associates’s Portfolio ONXX Stock Details ONXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-353,850
Closed -$44.1M – 2580
2013
Q3 		$44.1M Sell
353,850
-4,584,044
-93% -$580M 0.01% 864
2013
Q2 		$429M Buy
+4,937,894
New +$455M 0.11% 227

T. Rowe Price Associates's ONXX Position: Q4 2013 in Review

T. Rowe Price Associates sold out of ONYX PHARMACEUTICALS INC (ONXX) in Q4 2013, closing a stake of 353,850 shares — an estimated $44.1M sold.

T. Rowe Price Associates first reported a position in ONXX in Q2 2013 and held it in 2 quarters. The position peaked at $429M in Q2 2013. 0 funds tracked by Wall St. Rank hold ONXX as of Q4 2013.

  • T. Rowe Price Associates reported no remaining ONYX PHARMACEUTICALS INC position as of Q4 2013 after selling out during the quarter.
  • T. Rowe Price Associates sold 353,850 ONYX PHARMACEUTICALS INC shares in Q4 2013, an estimated $44.1M.
  • T. Rowe Price Associates first reported a position in ONYX PHARMACEUTICALS INC in Q2 2013 and held it in 2 quarters.
  • T. Rowe Price Associates's ONYX PHARMACEUTICALS INC position peaked at $429M in Q2 2013.
  • 0 funds tracked by Wall St. Rank held ONYX PHARMACEUTICALS INC as of Q4 2013.

Based on T. Rowe Price Associates's 13F filing for Q4 2013, filed 14 Feb 2014.